News for Kintor Pharmaceutical Limited (KNTPF)

Published at

Sep 30, 2024 3:00 PM

by globenewswire.com

mixed

mixed

Alopecia Treatment Market Size Expected to Reach USD 20.70 Billion by 2032 with 10.48% CAGR – SNS Insider

As Per SNS Insider, Alopecia Treatment Market Growth is Driven by Rising Demand for Hair Restoration Products, and Technological Advancements....

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE KNTPF CNCE 9939.HK SUNPHARMA-BL.NS MRKD.BA MRK.SN MRK.PA MRK.MX MRK JNJ GSK.L GSK GS7.DE GLAXF DJNJ3.BA DJNJ2.BA ACRS 6MK.DE

Read more →
Published at

Apr 22, 2024 4:04 AM

by investing.com

positive

positive

GT20029 China Phase II Trial For AGA Reached Primary Endpoint By Investing.com

GT20029 China Phase II Trial For AGA Reached Primary Endpoint

KNTPF 9939.HK

Read more →
Published at

Oct 28, 2023 4:35 AM

by marketscreener.com

mixed

mixed

Kintor Pharmaceutical : Pharma Announces Publication of Phase Ib/II Data from GT90001 and Nivolumab Combination Therapy for Advanced HCC in BMC Medicine -October 27, 2023 at 10:35 pm EDT

Suzhou, October 28, 2023 - Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that the...

KNTPF 9939.HK 8573.HK PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE

Read more →
Published at

Oct 11, 2023 10:39 AM

by marketscreener.com

positive

positive

Kintor Pharmaceutical : Pharma Announces the Approval of Phase II Clinical Trial of Hedgehog/SMO Inhibitor GT1708F for Treatment of IPF in China -October 11, 2023 at 04:39 am EDT

Suzhou, October 11, 2023 - Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that its...

KNTPF 9939.HK 8573.HK

Read more →
Published at

Aug 22, 2023 11:13 AM

by prnewswire.com

positive

positive

Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China

/PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...

KNTPF 9939.HK

Read more →
Published at

May 11, 2023 5:30 PM

by prnewswire.com

positive

positive

Kintor Pharma Announces Successful Completion of Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US

/PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...

KNTPF 9939.HK

Read more →
Published at

Mar 28, 2023 3:41 PM

by prnewswire.com

positive

positive

Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China

/PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...

KNTPF 9939.HK

Read more →
Published at

Mar 21, 2023 8:22 AM

by prnewswire.com

positive

positive

Kintor Pharma's KX-826 and GT20029 for Treatment of Androgenetic Alopecia (AGA) and Acne Presented at AAD 2023

/PRNewswire/ -- The 2023 Annual Meeting of American Academy of Dermatology Association (AAD 2023) was held from 17 to 21 March 2023 in New Orleans, Louisiana,...

KNTPF 9939.HK

Read more →
Published at

Feb 10, 2023 2:19 PM

by prnewswire.com

positive

positive

Kintor Pharma Announces Positive Top-line U.S. Phase I Trial Results of GT20029, the World's First Topical Use PROTAC Compound

/PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...

KNTPF 9939.HK

Read more →
Published at

Dec 1, 2022 12:30 PM

by prnewswire.com

positive

positive

Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826's Treatment of Female Androgenetic Alopecia in China Was Met

/PRNewswire/ -- Kintor Pharmaceutical Limited ("KintorPharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...

KNTPF 9939.HK

Read more →
Published at

Jul 25, 2022 7:00 PM

by globenewswire.com

mixed

mixed

Liver Cancer Pipeline Insight | Clinical Trial Research Evaluation Report

DelveInsight’s liver cancer pipeline report depicts a robust space with 100+ active players working to develop 100+ pipeline therapies for liver cancer...

TKBIF PVCT 4974.T KNTPF BPMC AVEO 9939.HK 0HOJ.L CSPHF CLSN 600276.SS 115180.KQ 0HUZ.L

Read more →